Compare RDY & SMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | SMTC |
|---|---|---|
| Founded | 1984 | 1960 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 9.6B |
| IPO Year | 2001 | 2002 |
| Metric | RDY | SMTC |
|---|---|---|
| Price | $14.39 | $135.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 15 |
| Target Price | $16.90 | ★ $93.20 |
| AVG Volume (30 Days) | 2.3M | ★ 3.6M |
| Earning Date | 05-12-2026 | 05-26-2026 |
| Dividend Yield | ★ 0.52% | N/A |
| EPS Growth | N/A | ★ 79.65 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $1,049,975,000.00 |
| Revenue This Year | $7.72 | $20.10 |
| Revenue Next Year | $3.50 | $13.01 |
| P/E Ratio | ★ $18.67 | $544.56 |
| Revenue Growth | N/A | ★ 15.47 |
| 52 Week Low | $12.19 | $46.02 |
| 52 Week High | $15.67 | $177.35 |
| Indicator | RDY | SMTC |
|---|---|---|
| Relative Strength Index (RSI) | 55.60 | 41.79 |
| Support Level | $13.80 | $67.57 |
| Resistance Level | $14.71 | $174.91 |
| Average True Range (ATR) | 0.34 | 11.53 |
| MACD | 0.05 | -3.98 |
| Stochastic Oscillator | 47.88 | 7.60 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Semtech Corp is a provider of high-performance semiconductors powering data center networking, Internet of Things ("IoT") connectivity, and cellular infrastructure solutions. The company designs, develops, manufactures, and markets a diverse portfolio of products for commercial applications, addressing the infrastructure, high-end consumer, and industrial end markets. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems, and Connected Services. The majority of the company's revenue is earned through the Analog Mixed Signal and Wireless segment. Geographically, the majority of the company's revenue is earned from the Asia Pacific region; the company also operates in North America and Europe.